help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dalm, V. A.
Right arrow Articles by Hofland, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dalm, V. A.
Right arrow Articles by Hofland, L. J.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 1 270-276
Copyright © 2003 by The Endocrine Society


Original Article

Cortistatin Rather Than Somatostatin as a Potential Endogenous Ligand for Somatostatin Receptors in the Human Immune System

Virgil A. Dalm, P. Martin van Hagen, Peter M. van Koetsveld, Anton W. Langerak, Aart-Jan van der Lely, Steven W. Lamberts and Leo J. Hofland

Departments of Internal Medicine (V.A.D., P.M.v.H., P.M.v.K., A.-J.v.d.L., S.W.L., L.J.H.) and Immunology (P.M.v.H., A.W.L.), Erasmus Medical Center, 3015 GD, Rotterdam, The Netherlands

Address all correspondence and requests for reprints to: L. J. Hofland, Ph.D., Department of Internal Medicine, Room BD277, Erasmus Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. E-mail: hofland{at}inw3.fgg.eur.nl.

Cells of the human immune system have been shown to express somatostatin receptors (sst). The expression of sst suggests a functional role of the peptide somatostatin (SS). However, SS expression has not been demonstrated yet in different human immune tissues. Therefore, we investigated by RT-PCR the expression of both SS and cortistatin (CST), a SS-like peptide, in various human lymphoid tissues and immune cells. We detected SS mRNA expression in the human thymus only, while not in thymocytes. CST mRNA was clearly expressed in the immune cells, lymphoid tissues, and bone marrow. Using quantitative RT-PCR, significant differences in expression levels between tissues were demonstrated. Expression of CST mRNA was up-regulated during differentiation of monocytes into macrophages and dendritic cells and could be up-regulated by lipopolysaccharide stimulation. Two differently sized cDNA fragments of CST were detected in the majority of cells and tissues. However, although both fragments were detected in nearly all T-cell lines (7 of 8), most of the B-cell lines expressed the short fragment only (8 of 10). Using autoradiography, we showed that CST displaced [125I-Tyr3]octreotide binding with relatively high affinity on human thymic tissue and sst2-expressing cells. This is the first extensive study demonstrating that human lymphoid tissues and immune cells express different levels of CST mRNA and that its expression can be regulated. On the basis of these observations, we hypothesize a role for CST as an endogenous ligand of at least the sst2 receptor in the human immune system, rather than SS itself.

This work was supported by a grant from the Dutch Organization for Scientific Research (NWO).

Abbreviations: CST, Cortistatin; HPRT, hypoxanthine-guanine phosphoribosyl transferase; LPS, lipopolysaccharide; PBMC, peripheral blood mononuclear cells; Q-PCR, quantitative RT-PCR; SS, somatostatin; sst, somatostatin receptor(s); TEC, thymic epithelial cells.




This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
N. Kimura, N. Takamatsu, Y. Yaoita, R Y. Osamura, and N. Kimura
Identification of transcriptional regulatory elements in the human somatostatin receptor sst2 promoter and regions including estrogen response element half-site for estrogen activation
J. Mol. Endocrinol., February 1, 2008; 40(2): 75 - 91.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
E. Gonzalez-Rey, A. Chorny, R. G Del Moral, N. Varela, and M. Delgado
Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses
Ann Rheum Dis, May 1, 2007; 66(5): 582 - 588.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. Armani, E. Catalani, A. Balbarini, P. Bagnoli, and D. Cervia
Expression, pharmacology, and functional role of somatostatin receptor subtypes 1 and 2 in human macrophages
J. Leukoc. Biol., March 1, 2007; 81(3): 845 - 855.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Rubinfeld, M. Hadani, G. Barkai, J. E. Taylor, M. D. Culler, and I. Shimon
Cortistatin Inhibits Growth Hormone Release from Human Fetal and Adenoma Pituitary Cells and Prolactin Secretion from Cultured Prolactinomas
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2257 - 2263.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
E. Gonzalez-Rey, A. Chorny, N. Varela, G. Robledo, and M. Delgado
Urocortin and Adrenomedullin Prevent Lethal Endotoxemia by Down-Regulating the Inflammatory Response
Am. J. Pathol., June 1, 2006; 168(6): 1921 - 1930.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
E. Gonzalez-Rey, A. Chorny, G. Robledo, and M. Delgado
Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia
J. Exp. Med., March 20, 2006; 203(3): 563 - 571.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Gonzalez-Rey, N. Varela, A. F. Sheibanie, A. Chorny, D. Ganea, and M. Delgado
Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease.
PNAS, March 14, 2006; 103(11): 4228 - 4233.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Seboek, P. Linscheid, H. Zulewski, I. Langer, M. Christ-Crain, U. Keller, and B. Muller
Somatostatin Is Expressed and Secreted by Human Adipose Tissue upon Infection and Inflammation
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4833 - 4839.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
V. A.S.H. Dalm, L. J. Hofland, C. M. Mooy, M. A. Waaijers, P. M. van Koetsveld, A. W. Langerak, F. T.J. Staal, A.-J. van der Lely, S. W.J. Lamberts, and M. P. van Hagen
Somatostatin Receptors in Malignant Lymphomas: Targets for Radiotherapy?
J. Nucl. Med., January 1, 2004; 45(1): 8 - 16.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. A. S. H. Dalm, P. M. van Hagen, P. M. van Koetsveld, S. Achilefu, A. B. Houtsmuller, D. H. J. Pols, A.-J. van der Lely, S. W. J. Lamberts, and L. J. Hofland
Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells
Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E344 - E353.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society